- Home
- LVS vs CAH Comparison
LVS vs CAH Comparison
Compare LVS & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVS
- CAH
- Stock Information
- Founded
- LVS 1988
- CAH 1979
- Country
- LVS United States
- CAH United States
- Employees
- LVS N/A
- CAH N/A
- Industry
- LVS Hotels/Resorts
- CAH Other Pharmaceuticals
- Sector
- LVS Consumer Discretionary
- CAH Health Care
- Exchange
- LVS Nasdaq
- CAH Nasdaq
- Market Cap
- LVS 37.8B
- CAH 37.6B
- IPO Year
- LVS 2004
- CAH N/A
- Fundamental
- Price
- LVS $53.01
- CAH $157.47
- Analyst Decision
- LVS Buy
- CAH Buy
- Analyst Count
- LVS 13
- CAH 14
- Target Price
- LVS $59.77
- CAH $161.43
- AVG Volume (30 Days)
- LVS 5.3M
- CAH 2.5M
- Earning Date
- LVS 10-22-2025
- CAH 10-30-2025
- Dividend Yield
- LVS 1.88%
- CAH 1.30%
- EPS Growth
- LVS N/A
- CAH 86.96
- EPS
- LVS 1.97
- CAH 6.45
- Revenue
- LVS $11,615,000,000.00
- CAH $222,578,000,000.00
- Revenue This Year
- LVS $9.31
- CAH $12.83
- Revenue Next Year
- LVS $4.94
- CAH $7.90
- P/E Ratio
- LVS $27.02
- CAH $24.38
- Revenue Growth
- LVS 1.62
- CAH N/A
- 52 Week Low
- LVS $30.18
- CAH $106.98
- 52 Week High
- LVS $58.05
- CAH $168.44
- Technical
- Relative Strength Index (RSI)
- LVS 46.67
- CAH 55.64
- Support Level
- LVS $50.64
- CAH $150.78
- Resistance Level
- LVS $55.45
- CAH $159.24
- Average True Range (ATR)
- LVS 1.45
- CAH 4.13
- MACD
- LVS -0.28
- CAH 0.44
- Stochastic Oscillator
- LVS 38.49
- CAH 76.11
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.